| CLBCX | JABNX | CLBCX / JABNX | |
| Total Expense Ratio | 1.35 | 0.57 | 237% |
| Annual Report Gross Expense Ratio | 1.35 | 0.57 | 237% |
| Fund Existence | 25 years | 14 years | - |
| Gain YTD | 9.840 | 6.764 | 145% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 283B | 27.8B | 1,018% |
| Annual Yield % from dividends | 1.09 | 1.76 | 62% |
| Returns for 1 year | 10.93 | 3.87 | 282% |
| Returns for 3 years | 40.94 | 34.72 | 118% |
| Returns for 5 years | 30.26 | 22.46 | 135% |
| Returns for 10 years | 80.98 | 107.96 | 75% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GIUIX | 45.05 | 0.21 | +0.47% |
| NAA Mid Growth Institutional | |||
| PIIIX | 18.49 | 0.02 | +0.11% |
| Principal Diversified Intl Inst | |||
| FSTRX | 42.57 | 0.02 | +0.05% |
| Federated Hermes MDT Large Cap Value A | |||
| BRUGX | 19.26 | 0.01 | +0.05% |
| MFS Blended Research Value Equity C | |||
| MRSJX | 30.02 | N/A | N/A |
| MFS Research International R4 | |||